Blue Owl Capital Holdings »

Geron Corporation shares owned by Blue Owl Capital Holdings

Quarter-by-quarter ownership of Geron Corporation (GERN) shares owned by Blue Owl Capital Holdings from 13F filings

Historical chart of Blue Owl Capital Holdings investment in Geron Corporation

Tip: Access up to 7 years of quarterly data

All positions including Geron Corporation held by Blue Owl Capital Holdings consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Geron Corporation by Blue Owl Capital Holdings

Quarter filed Position value Share count Share price at filing
2024-09-30 $109k 24k 4.54
2024-06-30 $101k 24k 4.24

More positions owned by Blue Owl Capital Holdings

Nuveen Churchill Direct Lend Com Shs (NCDL)
Klaviyo Com Ser A (KVYO)
Tourmaline Bio (TRML)
Pliant Therapeutics (PLRX)
Cullinan Oncology (CGEM)
Owl Rock Capital Corporation (OBDC)
Larimar Therapeutics (LRMR)
Proshares Tr Ultrapro Qqq (TQQQ)
Engene Holdings (ENGN)
Evercommerce (EVCM)
Acelyrin (SLRN)
Conduent Incorporate (CNDT)
Repare Therapeutics Ord (RPTX)
Context Therapeutics (CNTX)
Ultragenyx Pharmaceutical (RARE)

View all positions for Blue Owl Capital Holdings

Top funds holding Geron Corporation

BlackRock
BlackRock
RA Capital Management
Vanguard Group
State Street Corporation
Darwin Global Management
Leucadia National Corporation
Holocene Advisors
Farallon Capital Management
Geode Capital Management
Deep Track Capital
Goldman Sachs Group
Henderson Group
Eventide Asset Management
Woodline Partners

View all funds holding Geron Corporation